Sivaraj R.R., Durrani O.M., Denniston A.K. et al. Ocular manifestations of systemic lupus erythematosus // Rheumatology (Oxford). 2007. Vol. 46. N. 12. P. 1757–1762. DOI: https://doi.org/10.1093/rheumatology/kem173.
Tzung T.Y., Liu Y.S., Chang H.W. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study // Br. J. Dermatol. 2007. Vol. 156. N. 1. P. 191–192.
Wenzel J., Brahler S., Bauer R. et al. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients // Br. J. Dermatol. 2005. Vol. 153. N. 1. P. 157–162.
Winkelmann R.R., Kim G.K., Del Rosso J.Q. Treatment of cutaneous lupus erythematosus. Review and assessment of treatment benefits based on Oxford centre for evidence-based medicine criteria // J. Clin. Aesthet. Dermatol. 2013. Vol. 6. N. 1. P. 27–38.
Wozniacka A., McCauliffe D.P. Optimal use of antimalarials in treating cutaneous lupus erythematosus // Am. J. Clin. Dermatol. 2005. Vol. 6. N. 1. P. 1–11.
&hide_Cookie=yes)